MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # | show all

Keywords: radiobiology
BReP-SNAP-T-16A Probabilistic Poisson Model to Determine RBE Changes Facilitates LET-Based Optimization in Intensity Modulated Proton Treatment
M Brooke*, A Vella, F Van den Heuvel, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, GB
BReP-SNAP-T-80Impact of Radiation-Induced Oxygen Depletion On Cell Survival in Ultra-Short Pulsed Cell Irradiation at Low Repetition Rate
S Zhou*, D Zheng, Y Yan, S Wang, A Besemer, C Zhou, C Enke, University of Nebraska Medical Center, Omaha, NE
BReP-SNAP-T-124Single Cell Model with Complete Human Genome Using Geant4-DNA to Quantify Direct and Indirect Action Double-Strand Breaks
X Zhao*, R Liu, T Zhao, F Reynoso, Washington University in St. Louis, St. Louis, MO
MO-EF-TRACK 3-6Ultra-High Dose Rate (FLASH) Proton Beam Scanning in Clinical Gantry: Evaluation of Biological Benefit in Radiation Induced Skin Fibrosis and Muscle Atrophy
M Sertorio1*, K Vairamani1, S McCauley1, S Cunningham1, J Speth2, J Perentesis1, A Mascia2, (1) Cincinnati Children's Hospital Medical Center, Cincinnati, OH, (2) University of Cincinnati Medical Center, Cincinnati, OH
PO-GeP-M-49ALARA in a Flash - Radiation Shielding and Safety Implications Following Linac Conversion to An Electron FLASH-RT Unit
Y Poirier*, S Becker, S Mossahebi, N Lamichhane, A Sawant, University of Maryland School Of Medicine, Baltimore, MD
PO-GeP-T-8A Comparison of External Beam Radiotherapy and Radiopharmaceutical Lineal Energy Distributions Using Monte Carlo Track Structure Simulations
D Adam*, J Grudzinski, B Bednarz, University of Wisconsin, Madison, WI
PO-GeP-T-19A DNA-Based Detector for Quantification of DNA Damage From Ionizing Radiation
M Tambasco*, San Diego State University, San Diego, CA
PO-GeP-T-71A Study of the Effects of Vascular Damage On Tumor Volume After Hypo-Fraction Radiotherapy by Using a Cellular Automata Model
D Kawahara1*, L Wu2, Y Nagata1, Y Watanabe2, (1) Hiroshima University, Hiroshima, JP, (2) University of Minnesota, St. Paul, MN
PO-GeP-T-91Advancing RBE Models for High LET Particles Beyond the Linear-Quadratic Model
O Vassiliev*, C Peterson, D Grosshans, R Mohan, UT MD Anderson Cancer Center, Houston, TX
PO-GeP-T-155Biological Dosimetry of Spatially Modulated Proton Minibeam
N Cao1*, D Miles2, K Yagle1, D Argento1, G Moffitt5, R Emery1, J Meyer1, (1) University of Washington, Seattle, WA (2) Purdue Univ, West Lafayette, IN
PO-GeP-T-201Commissioning of An Xstrahl SARRP in the Novel Micro-RayStation Treatment Planning System
Y Poirier1*, A Anvari1,2, R Nilsson3, A Gerry1, C Johnstone1,4, A Sawant1, (1) University of Maryland School of Medicine, Baltimore, MD, (2) University of Pennsylvania Health System, Philadelphia, PA, (3) RaySearch Laboratories, Stockholm, SE, (4) Princess Margaret Cancer Centre, Toronto, ON, CA
PO-GeP-T-288Development of a Pre-Clinical MR-Guided Radiotherapy Model to Assess Gadolinium-Induced Renal Toxicity
M Petronek1*, E Steinbach1, A Kalen1, C Callaghan1, D Hyer1, R Flynn1, D Spitz1, J Buatti1, V Magnotta1, D Zepedo-orozco2, J St-Aubin1, B Allen1 (1) University of Iowa, Iowa City, IA, (2) Ohio State University, Columbus, OH
PO-GeP-T-356Dosimetry of a Preclinical Proton Irradiator
N Viscariello*, N Cao, J Meyer, University of Washington, Seattle, WA
PO-GeP-T-487Impact of Doped Samarium On Radiosensitizing Effects of Titanium Dioxide Nanoparticles in Vitro
M Nakayama1,2*, C Smith2, P Harty3, F Gagliardi2,4, M Geso2, (1) Division of Radiation Oncology, Kobe University, Kobe, Japan, (2) School of Biomedical and Health Sciences, RMIT University, Bundoora, VIC, Australia, (3) Australian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia, (4) Alfred Hospital, Melbourne, VIC, Australia
PO-GeP-T-517Incorporation of Experimental Uncertainties Associated with in Vitro Determination of Radiobiological Parameters Used in Cervical Cancer Brachytherapy
B Chow*, B Warkentin, A Gamper, G Menon, University of Alberta, Edmonton, AB, CAN
PO-GeP-T-583Modeling Direct and Indirect Action DSBs From Intracellular Gold Nanoparticles Using a Single Cell Model with Complete Human Genome in Geant4
X Zhao*, R Liu, T Zhao, F Reynoso, Washington University in St. Louis, St. Louis, MO
PO-GeP-T-584Modeling FLASH RT Effect for Ultra-Short Pulsed Cell Irradiation at High Repetition Rates
S Zhou*, D Zheng, Y Yan, S Wang, A Besemer, C Zhou, C Enke, University of Nebraska Medical Center, Omaha, NE
PO-GeP-T-768The Effect of Mouse Size On Dose Delivered to Mouse-Like Phantoms From An X-Rad 320 Irradiator
J Stasko*, C Hammer, W Culberson, University of Wisconsin Madison, Madison, WI
PO-GeP-T-809Treatment Planning Robustness for Intra-Pulse Motion
M Schwer*, E Klein, G Cardarelli, Rhode Island Hospital / Warren Alpert Medical School of Brown University, Providence, RI
PO-GeP-T-816Uncertainty Analysis for Relative Biological Effectiveness Derived From Different Dose-Effect Curve Model Fits
M Ghafarian*, J Eley, Vanderbilt University School of Medicine, Nashville, TN
PO-GeP-T-834Utilizing the Bragg Peak for Proton Flash Radiation
M Kim*, K Shoniyozov, C Koumenis, J Metz, K Cengel, L Dong, E Diffenderfer, University of Pennsylvania, Philadelphia, PA
TH-B-TRACK 3-2Effect of Photon Incidence Angle On the Accuracy of the Dose Point Kernel Method for Calculation of Gold Nanoparticle-Mediated Intracellular Dose Enhancement
S Jayarathna*, H Moktan, S H Cho, The University of Texas MD Anderson Cancer Center, Houston, TX
TH-B-TRACK 3-7Spatiotemporal Quantification of PSMA-Targeted Gold Nanoparticles Through X-Ray Fluorescence Computed Tomography
D Hara1*, J Ford2, (1) University of Miami, Miami, FL, (2) University of Miami Miller School of Medicine, Miami, FL
TH-B-TRACK 5-0Outcome Modeling and Response Prediction
X Li1*, I El Naqa2*, J Seuntjens3*, X Qi4*, (1) Medical College of Wisconsin, Milwaukee, WI, (2) University of Michigan, Ann Arbor, MI, (3) McGill University, Montreal, QC, (4) UCLA School of Medicine, Los Angeles, CA
TH-B-TRACK 5-1Introduction: outcome modeling and response prediction from analytic to data-driven
X Li1*, I El Naqa2*, J Seuntjens3*, X Qi4*, (1) Medical College of Wisconsin, Milwaukee, WI, (2) University of Michigan, Ann Arbor, MI, (3) McGill University, Montreal, QC, (4) UCLA School of Medicine, Los Angeles, CA
TH-B-TRACK 5-2Radiomics and radiogenomics modeling with machine learning
X Li1*, I El Naqa2*, J Seuntjens3*, X Qi4*, (1) Medical College of Wisconsin, Milwaukee, WI, (2) University of Michigan, Ann Arbor, MI, (3) McGill University, Montreal, QC, (4) UCLA School of Medicine, Los Angeles, CA
TH-B-TRACK 5-3Multimodality radiomics and deep learning for outcome modeling: application in head & neck cancer
X Li1*, I El Naqa2*, J Seuntjens3*, X Qi4*, (1) Medical College of Wisconsin, Milwaukee, WI, (2) University of Michigan, Ann Arbor, MI, (3) McGill University, Montreal, QC, (4) UCLA School of Medicine, Los Angeles, CA
TH-B-TRACK 5-4Opportunities and challenges of outcome modeling & response prediction for radiation therapy
X Li1*, I El Naqa2*, J Seuntjens3*, X Qi4*, (1) Medical College of Wisconsin, Milwaukee, WI, (2) University of Michigan, Ann Arbor, MI, (3) McGill University, Montreal, QC, (4) UCLA School of Medicine, Los Angeles, CA
TU-E-TRACK 5-0Mechanisms and Clinical Significance of Particle RBE
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-1An Introduction to the Problem of RBE in Particle Therapy
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-2Track-end objectives in intensity modulated proton therapy to reduce linear energy transfer
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-3Uncertainty and sensitivity analysis of biological modeling in proton and carbon ion treatment planning
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-4Proton Therapy and Variations in RBE - A Clinical Perspective
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-5Variable RBE (vRBE) Models are the Future of Particle Therapy Treatment Planning
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
WE-D-TRACK 3-3An Examination of the Mutational Signature of X-Ray Irradiation Using Single-Cell Whole Genome Sequencing
J J W Yeo*, R Li, Y C Wang, N Ybarra, J Kildea, I Ragoussis, McGill University, Montreal, QC, CA